Definitive Contract 75N95024C00040
Award Date
9/23/24
Potential Completion Date
9/22/25
Potential Value
$300K
Federal Agency
National Institute on Drug Abuse
Awardee
Vitruvian Bio, LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
East Case, MD 21202, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Mental Health (NIMH) to Giner Inc., a small business research and development firm based in Boston. The contract, valued at $306,499.12, is for the development of point-of-care HIV viral load and drug adherence assays. This aligns with NIMH's mission to advance research on mental health and HIV/AIDS. The contract was set aside for small businesses and is part of the broader DHHS SBIR/STTR...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, has awarded a $299,968 Small Business Innovation Research (SBIR) Phase I contract to Vitruvian Bio, LLC, a small disadvantaged and woman-owned business. The contract is for the development of an "Electrochemical Self-Monitoring Device for Rapid Nucleic Acid Based Testing of HIV-1". This specialized medical research and diagnostic technology...
This is a $299,976.31 Firm Fixed Price definitive contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Guild Associates Inc. (doing business as Guild Biosciences), a small business manufacturer. The contract is for the development of point-of-care HIV viral load and drug adherence assays under the NIH's Small Business Innovation Research (SBIR) program. This work was solicited under SBIR Topic 001 of the anticipated PHS-2024-1...
This is a $306,100 firm-fixed price contract awarded by the National Institute of Mental Health (NIMH), a component of the U.S. Department of Health and Human Services, to High Throughput Biology Inc., a small disadvantaged business concern, under the Small Business Innovation Research (SBIR) Phase I program. The contract supports the development of a quantitative and real-time point-of-care multiplex immunoassay to monitor adherence to antiretroviral (ART) and pre-exposure prophylaxis (PrEP)...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Darwin Biosciences, Inc., a minority-owned, woman-owned small business based in Broomfield, Colorado. The $299,408 firm-fixed-price contract is for the development of rapid diagnostic assays to aid in the self-monitoring of acute or rebound HIV-1 infection. The contract has an ultimate completion date of April 14, 2025. As an SBIR Phase I award,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The contract, with a ceiling value of $299,943.00, has been awarded to Lifetime Omics, Inc., a minority-owned, woman-owned, and small disadvantaged business. The contract is for research related to SBIR Topic 123, with a completion date of November 30, 2024. The contract is a definitive contract with a firm...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to Ai Biosciences, Inc., a minority-owned, self-certified small disadvantaged business, for the development of a low-cost, automated, and rapid home HIV viral load test. The award, which is part of the Small Business Innovation Research (SBIR) Program Phase I, has a potential value of $294,538.00 and a completion date of...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Virodx LLC, a minority-owned, woman-owned small business. The contract is for the development of a "METHOD FOR THE DETECTION OF MINORITY POPULATIONS OF DRUG RESISTANT HIV" and has a firm fixed price of $112,496.00 with a completion date of June 29, 2017. As this is an SBIR Phase I contract, the focus is on research...
This is a $299,988 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Zymeron Corporation, a minority-owned small business. The contract is for the development of novel, low-cost, real-time point-of-care (POC) assays for HIV viral load monitoring, HIV drug resistance monitoring, and pharmacological adherence monitoring. This contract was awarded under the Small Business Innovation...